drugset / Trial / NCT04500860
Low Dose Tadalafil for Treatment of Female OAB Syndrome: Short Term Follow up.
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluation of use of low dose tadalafil 5 mg daily for treatment of female OAB syndrome
Timeline
- Start
- 2020-12-01
- Primary completion
- 2022-07-01
- Completion
- 2022-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tadalafil | Small molecule | 5 mg | — |
| Comparator | Tolterodine | Small molecule | 4 mg | Oral |